Jayne Cottam Purchases 405 Shares of Assura Plc (LON:AGR) Stock

Assura Plc (LON:AGR - Get Free Report) insider Jayne Cottam purchased 405 shares of the firm's stock in a transaction on Wednesday, February 5th. The stock was bought at an average cost of GBX 37 ($0.46) per share, with a total value of £149.85 ($185.18).

Jayne Cottam also recently made the following trade(s):

• On Thursday, December 5th, Jayne Cottam acquired 369 shares of Assura stock. The stock was purchased at an average cost of GBX 41 ($0.51) per share, with a total value of £151.29 ($186.96).

Assura Price Performance

Shares of AGR stock traded down GBX 0.04 ($0.00) during mid-day trading on Tuesday, hitting GBX 37.74 ($0.47). 4,836,331 shares of the stock were exchanged, compared to its average volume of 8,015,011. Assura Plc has a 52-week low of GBX 35.24 ($0.44) and a 52-week high of GBX 43.96 ($0.54). The company has a quick ratio of 2.84, a current ratio of 0.89 and a debt-to-equity ratio of 85.04. The company has a market cap of £1.23 billion, a PE ratio of -3,774.00, a price-to-earnings-growth ratio of 3.60 and a beta of 0.37. The firm has a fifty day moving average of GBX 37.81 and a 200 day moving average of GBX 39.80.

Assura (LON:AGR - Get Free Report) last released its quarterly earnings results on Thursday, November 14th. The real estate investment trust reported GBX 1.70 ($0.02) earnings per share for the quarter. Assura had a negative return on equity of 1.88% and a negative net margin of 18.25%. Research analysts anticipate that Assura Plc will post 3.5830389 earnings per share for the current year.

Assura Dividend Announcement

The business also recently announced a dividend, which was paid on Wednesday, January 15th. Stockholders of record on Thursday, December 12th were given a GBX 0.84 ($0.01) dividend. The ex-dividend date was Thursday, December 12th. This represents a dividend yield of 2.12%. Assura's dividend payout ratio (DPR) is -30,000.00%.

Assura Company Profile

Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served. We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G). Assura plc achieved B Corp certification in July 2024 - the first FTSE 250 business to do so.